AlphaCentric Life Sciences and Healthcare Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 4.06 mm | 4.91 k shares | 9.18 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 3.71 mm | 7.09 k shares | 8.40 | Common equity | Long | USA |
JNJ Johnson & Johnson | 2.22 mm | 13.37 k shares | 5.02 | Common equity | Long | USA |
ABBV AbbVie Inc. | 2.20 mm | 10.50 k shares | 4.98 | Common equity | Long | USA |
ASTRAZENECA-ADR
|
1.87 mm | 25.46 k shares | 4.23 | Common equity | Long | UK |
MRK Merck & Co., Inc. | 1.64 mm | 18.32 k shares | 3.72 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 1.53 mm | 15.19 k shares | 3.47 | Common equity | Long | USA |
NVS Novartis AG | 1.42 mm | 12.73 k shares | 3.21 | Common equity | Long | Switzerland |
TMO Thermo Fisher Scientific Inc. | 1.33 mm | 2.68 k shares | 3.02 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 1.19 mm | 2.46 k shares | 2.70 | Common equity | Long | USA |
GMED Globus Medical, Inc. | 1.08 mm | 14.74 k shares | 2.44 | Common equity | Long | USA |
ABT Abbott Laboratories | 1.01 mm | 7.59 k shares | 2.28 | Common equity | Long | USA |
ISRG Intuitive Surgical, Inc. | 995.49 k | 2.01 k shares | 2.25 | Common equity | Long | USA |
CVS CVS Health Corporation | 983.59 k | 14.52 k shares | 2.23 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 967.18 k | 15.86 k shares | 2.19 | Common equity | Long | USA |
Cigna Holding Co | 955.42 k | 2.90 k shares | 2.16 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 950.97 k | 8.49 k shares | 2.15 | Common equity | Long | USA |
FIRST AM-TR OB-X | 843.76 k | 843.76 k principal | 1.91 | Short-term investment vehicle | Long | USA |
PFE Pfizer Inc. | 792.36 k | 31.27 k shares | 1.79 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 716.27 k | 3.13 k shares | 1.62 | Common equity | Long | USA |
DHR Danaher Corporation | 686.75 k | 3.35 k shares | 1.55 | Common equity | Long | USA |
ELV Elevance Health Inc. | 679.84 k | 1.56 k shares | 1.54 | Common equity | Long | USA |
ATRC AtriCure, Inc. | 677.30 k | 21.00 k shares | 1.53 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 592.82 k | 5.36 k shares | 1.34 | Common equity | Long | USA |
EHC Encompass Health Corporation | 565.55 k | 5.58 k shares | 1.28 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 550.41 k | 7.59 k shares | 1.25 | Common equity | Long | USA |
ZBH Zimmer Biomet Holdings, Inc. | 530.81 k | 4.69 k shares | 1.20 | Common equity | Long | USA |
CHE Chemed Corporation | 518.71 k | 843.00 shares | 1.17 | Common equity | Long | USA |
SYK Stryker Corporation | 498.82 k | 1.34 k shares | 1.13 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 415.76 k | 9.60 k shares | 0.94 | Common equity | Long | USA |
TERUMO CORP-ADR
|
411.08 k | 21.89 k shares | 0.93 | Common equity | Long | Japan |
HOLX Hologic, Inc. | 386.31 k | 6.25 k shares | 0.87 | Common equity | Long | USA |
DXCM DexCom, Inc. | 350.81 k | 5.14 k shares | 0.79 | Common equity | Long | USA |
VRNA Verona Pharma plc | 340.31 k | 5.36 k shares | 0.77 | Common equity | Long | UK |
ZTS Zoetis Inc. | 330.95 k | 2.01 k shares | 0.75 | Common equity | Long | USA |
USPH U.S. Physical Therapy, Inc. | 307.10 k | 4.24 k shares | 0.69 | Common equity | Long | USA |
IRTC iRhythm Technologies, Inc. | 303.99 k | 2.90 k shares | 0.69 | Common equity | Long | USA |
WST West Pharmaceutical Services, Inc. | 300.00 k | 1.34 k shares | 0.68 | Common equity | Long | USA |
DAIICHI SAN-ADR
|
298.69 k | 12.51 k shares | 0.68 | Common equity | Long | Japan |
NEOG Neogen Corporation | 298.21 k | 34.40 k shares | 0.67 | Common equity | Long | USA |
ADPT Adaptive Biotechnologies Corporation | 295.39 k | 39.76 k shares | 0.67 | Common equity | Long | USA |
AORT Artivion, Inc. | 289.48 k | 11.78 k shares | 0.65 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 281.81 k | 1.56 k shares | 0.64 | Common equity | Long | USA |
ICLR ICON Public Limited Company | 273.51 k | 1.56 k shares | 0.62 | Common equity | Long | Ireland |
RYTM Rhythm Pharmaceuticals, Inc. | 272.11 k | 5.14 k shares | 0.62 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 267.65 k | 422.00 shares | 0.61 | Common equity | Long | USA |
INSM Insmed Incorporated | 238.56 k | 3.13 k shares | 0.54 | Common equity | Long | USA |
COR Cencora, Inc. | 234.43 k | 843.00 shares | 0.53 | Common equity | Long | USA |
KIDS OrthoPediatrics Corp. | 225.54 k | 9.16 k shares | 0.51 | Common equity | Long | USA |
ALDX Aldeyra Therapeutics, Inc. | 217.05 k | 37.75 k shares | 0.49 | Common equity | Long | USA |
SGRY Surgery Partners, Inc. | 212.18 k | 8.93 k shares | 0.48 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 211.61 k | 27.03 k shares | 0.48 | Common equity | Long | Ireland |
APGE Apogee Therapeutics, Inc. | 207.95 k | 5.57 k shares | 0.47 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 205.24 k | 4.24 k shares | 0.46 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 188.68 k | 6.25 k shares | 0.43 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 181.81 k | 8.26 k shares | 0.41 | Common equity | Long | USA |
BNTX BioNTech SE | 153.62 k | 1.69 k shares | 0.35 | Common equity | Long | Germany |
AGIO Agios Pharmaceuticals, Inc. | 150.51 k | 5.14 k shares | 0.34 | Common equity | Long | USA |
CRL Charles River Laboratories International, Inc. | 126.89 k | 843.00 shares | 0.29 | Common equity | Long | USA |
TNDM Tandem Diabetes Care, Inc. | 124.10 k | 6.48 k shares | 0.28 | Common equity | Long | USA |
ADUS Addus HomeCare Corporation | 116.20 k | 1.18 k shares | 0.26 | Common equity | Long | USA |
SDZNY Sandoz Group AG | 103.00 k | 2.46 k shares | 0.23 | Common equity | Long | Switzerland |
ORKA Oruka Therapeutics, Inc. | 50.42 k | 4.91 k shares | 0.11 | Common equity | Long | USA |
FID-MM GOVT-I | 1.51 | 1.51 principal | 0.00 | Short-term investment vehicle | Long | USA |